From: Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer
ID | Description | p value | p.adjust | q value | Count | gene_symbol |
---|---|---|---|---|---|---|
hsa04514 | Cell adhesion molecules (CAMs) | 1.98E-10 | 1.98E-10 | 8.55E-09 | 11 | CTLA4/CD8A/CD8B/TIGIT/HLA-DRB1/ICOS/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa04658 | Th1 and Th2 cell differentiation | 9.90E-10 | 9.90E-10 | 2.14E-08 | 9 | IL12RB1/TBX21/HLA-DRB1/CD3D/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1/LCK |
hsa04640 | Hematopoietic cell lineage | 1.92E-09 | 1.92E-09 | 2.76E-08 | 9 | CD8A/CD8B/HLA-DRB1/CD3D/HLA-DPB1/HLA-DQA1/HLA-DRA/FCGR1A/HLA-DPA1 |
hsa04659 | Th17 cell differentiation | 3.86E-09 | 3.86E-09 | 4.16E-08 | 9 | IL12RB1/TBX21/HLA-DRB1/CD3D/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1/LCK |
hsa04060 | Cytokine-cytokine receptor interaction | 2.07E-05 | 2.07E-05 | 3.58E-05 | 9 | CXCL9/CCL4/CCL5/IL12RB1/CD27/CXCR6/CXCL13/CXCR3/CCR5 |
hsa04612 | Antigen processing and presentation | 6.37E-09 | 6.37E-09 | 4.58E-08 | 8 | CD8A/CD8B/CD74/HLA-DRB1/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05323 | Rheumatoid arthritis | 2.61E-08 | 2.61E-08 | 1.41E-07 | 8 | CTLA4/CCL5/HLA-DRB1/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05322 | Systemic lupus erythematosus | 4.29E-07 | 4.29E-07 | 1.23E-06 | 8 | HLA-DRB1/CD86/HLA-DPB1/FCGR3A/HLA-DQA1/HLA-DRA/FCGR1A/HLA-DPA1 |
hsa04145 | Phagosome | 1.19E-06 | 1.19E-06 | 2.70E-06 | 8 | HLA-DRB1/HLA-DPB1/FCGR3A/HLA-DQA1/OLR1/HLA-DRA/FCGR1A/HLA-DPA1 |
hsa05152 | Tuberculosis | 4.24E-06 | 4.24E-06 | 8.72E-06 | 8 | CD74/HLA-DRB1/HLA-DPB1/FCGR3A/HLA-DQA1/HLA-DRA/FCGR1A/HLA-DPA1 |
hsa04062 | Chemokine signaling pathway | 6.10E-06 | 6.10E-06 | 1.14E-05 | 8 | CXCL9/CCL4/CCL5/CXCR6/CXCL13/CXCR3/CCR5/GNGT2 |
hsa04672 | Intestinal immune network for IgA production | 5.76E-09 | 5.76E-09 | 4.58E-08 | 7 | HLA-DRB1/ICOS/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05320 | Autoimmune thyroid disease | 1.02E-08 | 1.02E-08 | 6.27E-08 | 7 | CTLA4/HLA-DRB1/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05321 | Inflammatory bowel disease (IBD) | 4.38E-08 | 4.38E-08 | 1.72E-07 | 7 | IL12RB1/TBX21/HLA-DRB1/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05140 | Leishmaniasis | 1.44E-07 | 1.44E-07 | 4.45E-07 | 7 | HLA-DRB1/HLA-DPB1/FCGR3A/HLA-DQA1/HLA-DRA/FCGR1A/HLA-DPA1 |
hsa04660 | T cell receptor signaling pathway | 1.14E-06 | 1.14E-06 | 2.70E-06 | 7 | CTLA4/CD8A/CD8B/ICOS/CD3D/LCP2/LCK |
hsa04380 | Osteoclast differentiation | 4.63E-06 | 4.63E-06 | 9.08E-06 | 7 | SIRPG/LILRB2/LILRB1/FCGR3A/FCGR1A/LCP2/LCK |
hsa05166 | Human T cell leukemia virus 1 infection | 0.000148 | 0.000148 | 0.000237 | 7 | HLA-DRB1/CD3D/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1/LCK |
hsa05168 | Herpes simplex virus 1 infection | 0.014966 | 0.014966 | 0.018997 | 7 | CCL5/CD74/HLA-DRB1/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05330 | Allograft rejection | 4.14E-08 | 4.14E-08 | 1.72E-07 | 6 | HLA-DRB1/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05332 | Graft-versus-host disease | 6.67E-08 | 6.67E-08 | 2.40E-07 | 6 | HLA-DRB1/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa04940 | Type I diabetes mellitus | 8.97E-08 | 8.97E-08 | 2.98E-07 | 6 | HLA-DRB1/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05416 | Viral myocarditis | 6.88E-07 | 6.88E-07 | 1.75E-06 | 6 | HLA-DRB1/CD86/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05145 | Toxoplasmosis | 2.67E-05 | 2.67E-05 | 4.44E-05 | 6 | HLA-DRB1/HLA-DPB1/HLA-DQA1/HLA-DRA/CCR5/HLA-DPA1 |
hsa05164 | Influenza A | 0.000272 | 0.000272 | 0.000419 | 6 | CCL5/HLA-DRB1/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05169 | Epstein-Barr virus infection | 0.000665 | 0.000665 | 0.000989 | 6 | HLA-DRB1/CD3D/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa05310 | Asthma | 5.48E-07 | 5.48E-07 | 1.48E-06 | 5 | HLA-DRB1/HLA-DPB1/HLA-DQA1/HLA-DRA/HLA-DPA1 |
hsa04620 | Toll-like receptor signaling pathway | 0.002276 | 0.002276 | 0.003274 | 4 | CXCL9/CCL4/CCL5/CD86 |
hsa04650 | Natural killer cell mediated cytotoxicity | 0.005222 | 0.005222 | 0.007042 | 4 | FCGR3A/SH2D1A/LCP2/LCK |
hsa04623 | Cytosolic DNA-sensing pathway | 0.004625 | 0.004625 | 0.006439 | 3 | CCL4/CCL5/ZBP1 |
hsa04662 | B cell receptor signaling pathway | 0.00961 | 0.00961 | 0.012568 | 3 | LILRB2/CD72/LILRB1 |